4T1 In Vitro High-throughput Screening (HTS) Assay
CAT#: ITS-1022-YF515
Target Cell Organism: Mouse
Target Cell Name: 4T1
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
Assay Overview
This assay is to provide 4T1-based In Vitro High-throughput Screening (HTS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
4T1
Target Cell Organism
Mouse
Target Cell Background
4T1 is a breast cancer cell line derived from the mammary gland tissue of a mouse BALB/c strain. 4T1 cells are epithelial and are resistant to 6-thioguanine. In preclinical research, 4T1 cells have been used to study breast cancer metastasis as they can metastasize to the lung, liver, lymph nodes, brain and bone.
Related Diseases
Breast Cancer
Research Area
Oncology
Assay Name
In Vitro High-throughput Screening (HTS) Assay
Short Description
4T1-cell based In Vitro High-throughput Screening (HTS) Assay
Assay Description
HTS is one of the modern technologies used in cancer drug discovery. This technique enables to screen or assay thousands of chemical compounds against a target of interest within a short period. HTS is also useful in screening different libraries such as synthetic compounds, combinatorial chemistry, peptides and genomic libraries and obtaining toxicological and pharmacokinetic data related to chemical compounds. HTS has gained much attention among scientists and industries as a large number of compounds prepared by chemical synthesis methods can be screened within a short period, which can reduce the cost of drug discovery and animal use. HTS consist of major steps such as identification of targets, preparation of reagents, management of test compounds, development of suitable assay procedures and screening.
Assay Type
High-throughput Screening, High Content Screening and Reporter Gene Assays